Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Despite Cleaning, Bacterial Biofilms Remain Within Colonoscopes

XTALKS VITALS NEWS

Colonoscope

According to the authors of the study – which was published in the American Journal of Infection Control – microscopic scratches and dents in these medical devices can allow for the growth of bacterial biofilms.

Share this!

February 2, 2017 | by Sarah Hand, M.Sc.

Colonoscopes and other gastrointestinal devices are rigorously cleaned between procedures, however a new study has found that these practices may not be enough to remove contaminants such as bacteria and other biological material. According to the authors of the study – which was published in the American Journal of Infection Control – microscopic scratches and dents in these medical devices can allow for the growth of bacterial biofilms.

The researchers studied scopes manufactured by Japanese medical device maker, Olympus Corp., over a seven-month period. These gastroscopes and colonoscopies were routinely disinfected following current guidelines, however 12 of the 20 scopes in use tested positive for bacterial growth.

What’s more, 17 of the scopes were found to have significant scratches and dents, leading them to be returned to Olympus for repair. These defects not only allow for the multiplication of bacteria, but also cause blood and debris to accumulate.



“Physicians, other caregivers, hospitals and regulators should be paying keen attention to this issue, as patients have a right to assume that clean instruments are being used on them,” said Cori Ofstead, an epidemiologist in St. Paul, Minnesota, and the first author of the study.

In recent years, gastrointestinal scopes have been linked to a number of cases of antibiotic-resistant bacterial infections, some of which were fatal. While contaminated duodenoscopes have been implicated in the most of these cases of illness, the current study suggests users of other types of scopes may also be at risk.

Unlike other studies however, the bacterial species identified on the scopes by Ofstead and his colleagues were not drug-resistant. Still the study suggests that all health centers should be more vigilant when it comes to scope maintenance.

“The FDA continues to actively monitor challenges associated with reprocessing reusable medical devices and to look for ways to reduce the risk of infection with reprocessed endoscopes,” said Deborah Kotz, a spokeswoman from the US Food and Drug Administration (FDA). The agency has also encouraged hospitals to stop using any scopes that show signs of damage.


Keywords: Biofilm, Colonoscope, Medical Device


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Kite Pharma Secures FDA Approval for CAR-T Immunotherapy

October 20, 2017 - Kite Pharma’s Yescarta (axicabtagene ciloleucel) has become the second CAR-T immunotherapy to be approved in the US, with an indication in treating adult patients with relapsed or refractory large B-cell lymphoma.

Featured In: Biotech News


Fallopian Tubes Found to be Site of Origin for Most Ovarian Cancers

October 20, 2017 - This year, over 22,000 women will be diagnosed with ovarian cancer but a new study conducted by researchers at Perlmutter Cancer Center at NYU Langone Health suggests that most of these malignancies begin in another part of the reproductive system: the fallopian tubes.

Featured In: Life Science News


Food Companies are Looking for the Next Sriracha

October 19, 2017 - The Sriracha trend might be coming to an end and companies are looking for the next big hot sauce star to feature in their line-up.

Featured In: Food News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub

REGISTER FOR THESE WEBINARS

Brexit – Separating Fact from Fiction


Evolving Best Practices for Working with Authors of Scientific Publications – Authorship and Beyond


Human Whole-Genome Sequencing in a New Era Defined by the Illumina® HiSeq X® and NovaSeq™ Platforms


Clinical Event Adjudication: Comprehensive and Efficient Dossier Review Using a Global On-Line Solution


Copyright © 2016-2017 Honeycomb Worldwide Inc.